<?xml version="1.0" encoding="utf-8"?>
<Journal>
<Journal-Info>
<name>International Journal of Pharma and Bio Sciences</name>
<website>ijpbs.net</website>
<email>editorijpbs@rediffmail.com (or) editorofijpbs@yahoo.com (or) prasmol@rediffmail.com</email>
</Journal-Info>
<article>
<article-id pub-id-type='other'>10.22376/ijpbs.2019.10.1.p1-12</article-id>
<issue_number>Volume 1 Issue 3</issue_number>
<issue_period>2010 (July - September) </issue_period>
<title>Clinical Aspects of Ebola Hemorrhagic Fever: A Review</title>
<abstract>Ebola hemorrhagic fever is a viral disease marked by fever, systemic hemorrhage, and high mortality; it affects humans and monkeys and has appeared in epidemic form in Africa and Germany. The cause is one of the three subtypes of viruses in the Filoviridae family that is distinguished by long thread like strands of RNA. The animal or insect host (reservoir) has not been identified, limiting study of the disease. The three filoviruses known to cause disease in humans are the Marburg virus, Zaire virus, and Sudan virus. The fourth subtype, the Reston virus, is fatal to monkeys, but did not produce disease in infected. In the present article, we have concentrated on clinical features, diagnosis, transmission, prevention and treatment of Ebola hemorrhagic fever. The aim of present article is to provide in depth knowledge about the clinical aspects of Ebola hemorrhagic fever. </abstract>
<authors>Satyanand Tyagi,Sachin Kumar,Mohit Singla</authors>
<keywords>Ebola hemorrhagic fever, Ebola Virus, Filovirus and Viral hemorrhagic fever. </keywords>
<pages>-</pages>
</article>
</Journal>
